2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
367-05-008 ISMRM Abstract

Patterns of Expanding Lesions in Multiple Sclerosis: Associations with Microstructural Changes and Neuroaxonal Damage

Accepted
Martina Greselin 1,2, Po-Jui Lu1,2, Alessandro Cagol1,2,3, Esther Ruberte1,2, Sabine Schädelin1,2,4, Lester Melie Garcia1,2, Xinjie Chen1,2, Riccardo Galbusera1,2, Mario Ocampo-Pineda1,2, Matthias Weigel1,2, Jens Kuhle1,2, Ludwig Kappos1,2, Habib Ganjgahi5,6, Frederik Lange7, Thomas Nichols5,6, Dieter Häring8, Elizabeth Fisher8, Laura Gaetano8, Cristina Granziera1,2
1University Hospital Basel, Basel, Basel-Stadt, Switzerland
2Department of Neurology, University Hospital Basel, Basel, Basel-Stadt, Switzerland
3Department of Health Sciences, University of Genova, Genova, Italy
4Department of Clinical Research, University Hospital Basel, Basel, Basel-Stadt, Switzerland
5Big Data Institute, Oxford, United Kingdom
6Statistics Department, University of Oxford, Oxford, England, United Kingdom
7Oxford Centre for Integrative Neuroimaging, Oxford, England, United Kingdom
8Novartis Pharma AG, Basel, Switzerland
Presenting Author: Martina Greselin

Synopsis

Motivation:
Goals:
Approach:
Results:
Preview figure: Patterns of Expanding Lesions in Multiple Sclerosis:  Associations with Microstructural Changes and Neuroaxonal Damage
Preview figure
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public on 13 May 2028.

To request or purchase access, contact the ISMRM Central Office at support@ismrm.org.

Log in

References

1. H. Lassmann, J. Van Horssen, and D. Mahad, “Progressive multiple sclerosis: Pathology and pathogenesis,” 2012, Nature Publishing Group. doi: 10.1038/nrneurol.2012.168. [doi]
2. Disanto et al., “The Swiss Multiple Sclerosis Cohort-Study (SMSC): A prospective Swiss wide investigation of key phases in disease evolution and new treatment options,” PLoS One, vol. 11, no. 3, Mar. 2016, doi: 10.1371/journal.pone.0152347. [doi]
3. University Hospital, Basel, Switzerland, “Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis (INsIDER).” ClinicalTrials.gov ID: NCT05177523 Accessed: Oct. 29, 2025. [Online]. Available: https://www.clinicaltrials.gov/study/NCT05177523
4. S. Grahl et al., “Evidence for a white matter lesion size threshold to support the diagnosis of relapsing remitting multiple sclerosis,” Mult Scler Relat Disord, vol. 29, pp. 124–129, Apr. 2019, doi: 10.1016/j.msard.2019.01.042. [doi]
5. F. La Rosa et al., “Multiple sclerosis cortical and WM lesion segmentation at 3T MRI: a deep learning method based on FLAIR and MP2RAGE,” Neuroimage Clin, vol. 27, Jan. 2020, doi: 10.1016/j.nicl.2020.102335. [doi]
6. J. Lange et al., “MMORF—FSL’s MultiMOdal Registration Framework,” Imaging Neuroscience, vol. 2, pp. 1–30, Mar. 2024, doi: 10.1162/imag_a_00100. [doi]

Cite this abstract